Antidepressants and risk of dementia in migraine patients: A population‐based case‐control study

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Progress in Neuro-psychopharmacology and Biological Psychiatry

• Publication date

  2017-07-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pnpbp.2017.04.006PMID 28392483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Methods to control for unmeasured confounding in pharmacoepidemiology: an overview

  2016cited by this paper
• Neuropathological relationship between major depression and dementia: A hypothetical model and review.

  2016cited by this paper
• The missing cause approach to unmeasured confounding in pharmacoepidemiology

  2016cited by this paper
• Fluoxetine ameliorates cognitive impairments induced by chronic cerebral hypoperfusion via down-regulation of HCN2 surface expression in the hippocampal CA1 area in rats.

  2016cited by this paper
• Antidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia

  2016cited by this paper
• Antidepressant treatment and risk of dementia: a population-based, retrospective case-control study.

  2016influential reference
• New therapeutic approaches for the prevention and treatment of migraine.

  2015cited by this paper
• Escitalopram Ameliorates Forskolin-Induced Tau Hyperphosphorylation in HEK239/tau441 Cells

  2015cited by this paper
• Statins are associated with a reduced risk of cholangiocarcinoma: a population-based case-control study.

  2015cited by this paper
• Cognitive dysfunction in depression - pathophysiology and novel targets.

  2015cited by this paper
• Dementia risk estimates associated with measures of depression: a systematic review and meta-analysis

  2015cited by this paper
• Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice.

  2015cited by this paper
• Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.

  2014cited by this paper
• An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice

  2014cited by this paper
• Venlafaxine inhibits apoptosis of hippocampal neurons by up-regulating brain-derived neurotrophic factor in a rat depression model.

  2014cited by this paper
• Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease

  2014cited by this paper
• Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?

  2014cited by this paper
• Migraine and Risk of Dementia: A Nationwide Retrospective Cohort Study

  2013influential reference
• Cardiovascular Considerations in Antidepressant Therapy: An Evidence-Based Review

  2013cited by this paper
• The pathobiology of vascular dementia.

  2013cited by this paper
• Antidepressant use and cognitive deficits in older men: addressing confounding by indications with different methods.

  2012cited by this paper
• The Effect of Duloxetine Treatment on Cognition in Patients With Fibromyalgia

  2012cited by this paper
• Do continued antidepressants protect against dementia in patients with severe depressive disorder?

  2011cited by this paper
• Psychopharmacological neuroprotection in neurodegenerative disease: heuristic clinical applications.

  2010cited by this paper
• Comorbidities of Migraine

  2010influential reference
• Tricyclic antidepressants for migraine and tension-type headaches

  2010cited by this paper
• Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.

  2010cited by this paper
• Fluoxetine protects against amyloid-beta toxicity, in part via daf-16 mediated cell signaling pathway, in Caenorhabditis elegans.

  2010cited by this paper
• Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder.

  2010cited by this paper
• Dementia, stroke and migraine--some common pathological mechanisms.

  2010cited by this paper
• Antidepressants and dementia.

  2009cited by this paper
• [Treatment guidelines for preventive treatment of migraine].

  2008cited by this paper
• Confounding by severity and indication in observational studies of antidepressant effectiveness.

  2008cited by this paper
• Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.

  2007cited by this paper
• The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.

  2005cited by this paper
• Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

  2004cited by this paper
• Bupropion: a review of its mechanism of antidepressant activity.

  1995cited by this paper
• Noradrenergic modulation of central serotonergic neurotransmission: acute and long-term actions of mirtazapine

  1995cited by this paper

• Resolving a paradox: antidepressants, neuroinflammation, and neurodegeneration

  2024cites this paper
• A 12-week randomized double-blind clinical trial of eicosapentaenoic acid intervention in episodic migraine.

  2024cites this paper
• Expanding the scope of health disparities research in Alzheimer's disease and related dementias

  2023cites this paper
• The mysterious connection between migraine and dementia: epiphenomenon or causation? Special considerations

  2022cites this paper
• Migraine

  2021cites this paper
• Headache - A Window to Dementia: An Unexpected Twist

  2021influential citation
• Use of sedative‐hypnotic medications and risk of dementia: A systematic review and meta‐analysis

  2021cites this paper
• An Agenda for Addressing Multimorbidity and Racial and Ethnic Disparities in Alzheimer’s Disease and Related Dementia

  2020cites this paper
• Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies.

  2019cites this paper
• Association between Cervical Spondylosis and Migraine: A Nationwide Retrospective Cohort Study

  2018cites this paper
• Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies

  2018cites this paper
• Comparison of treatment outcomes between fibromyalgia and the incomplete form of fibromyalgia with the same treatment

  2018influential citation
• The Medication Guidelines for Neuropathic Pain Including Fibromyalgia is justified from a Scientific Viewpoint, However, it does Not Necessarily Agree with Clinical Priority

  2018cites this paper
• Exploration of Neuroprotective Therapy

  year unknowncites this paper